These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12133729)

  • 1. New asthma targets: recent clinical and preclinical advances.
    Greenfeder S; Anthes JC
    Curr Opin Chem Biol; 2002 Aug; 6(4):526-33. PubMed ID: 12133729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Th2 cells in asthmatic airways.
    Caramori G; Ito K; Adcock IM
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):243-55. PubMed ID: 15379592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs for asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2008 Dec; 13(4):643-53. PubMed ID: 19046132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting T cells for asthma.
    Heijink IH; Van Oosterhout AJ
    Curr Opin Pharmacol; 2005 Jun; 5(3):227-31. PubMed ID: 15907907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TH2 cytokines and associated transcription factors as therapeutic targets in asthma.
    Nakamura Y; Hoshino M
    Curr Drug Targets Inflamm Allergy; 2005 Apr; 4(2):267-70. PubMed ID: 15853749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th2 cytokine antagonists: potential treatments for severe asthma.
    Hansbro PM; Scott GV; Essilfie AT; Kim RY; Starkey MR; Nguyen DH; Allen PD; Kaiko GE; Yang M; Horvat JC; Foster PS
    Expert Opin Investig Drugs; 2013 Jan; 22(1):49-69. PubMed ID: 23126660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach.
    Zaffini R; Gotte G; Menegazzi M
    Drug Des Devel Ther; 2018; 12():281-293. PubMed ID: 29483769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-directed therapy in asthma.
    Ichinose M; Barnes PJ
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):263-9. PubMed ID: 15379594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18β-Glycyrrhetinic acid, the major bioactive component of Glycyrrhizae Radix, attenuates airway inflammation by modulating Th2 cytokines, GATA-3, STAT6, and Foxp3 transcription factors in an asthmatic mouse model.
    Kim SH; Hong JH; Lee JE; Lee YC
    Environ Toxicol Pharmacol; 2017 Jun; 52():99-113. PubMed ID: 28410469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targets for asthma therapy.
    Boushey H
    Allerg Immunol (Paris); 2000 Nov; 32(9):336-41. PubMed ID: 11195856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment targets of asthma: from laboratory to clinic.
    Fang C; Corrigan CJ; Ying S
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):119-28. PubMed ID: 18691142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
    Chung KF
    J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus subtilis KCTC 11782BP-produced alginate oligosaccharide effectively suppresses asthma via T-helper cell type 2-related cytokines.
    Bang MA; Seo JH; Seo JW; Jo GH; Jung SK; Yu R; Park DH; Park SJ
    PLoS One; 2015; 10(2):e0117524. PubMed ID: 25658604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research on inflammatory mediators in asthma: new therapeutic approaches].
    Magnan A; Molimard M; Braunstein G; Devillier P
    Therapie; 1999; 54(4):447-61. PubMed ID: 10667111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New immunological approaches and cytokine targets in asthma and allergy.
    Stirling RG; Chung KF
    Eur Respir J; 2000 Dec; 16(6):1158-74. PubMed ID: 11292123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ciclesonide treatment on allergen-induced changes in T cell regulation in asthma.
    Heijink IH; Kauffman HF; Vellenga E; Veltman-Starkenburg CA; Postma DS; de Monchy JG
    Int Arch Allergy Immunol; 2008; 145(2):111-21. PubMed ID: 17848804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.
    Levine SJ; Wenzel SE
    Ann Intern Med; 2010 Feb; 152(4):232-7. PubMed ID: 20157138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
    Fajt ML; Wenzel SE
    J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propofol inhibits T-helper cell type-2 differentiation by inducing apoptosis via activating gamma-aminobutyric acid receptor.
    Meng J; Xin X; Liu Z; Li H; Huang B; Huang Y; Zhao J
    J Surg Res; 2016 Dec; 206(2):442-450. PubMed ID: 27884341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives in asthma treatment.
    Pelaia G; Vatrella A; Calabrese C; Mazzarella G; Marsico SA
    Allergy; 2000; 55 Suppl 61():60-6. PubMed ID: 10919510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.